Evidence map›Paper›PMID 34069293›Full record

ReviewInternational journal of molecular sciences2021

Recent Update on the Molecular Mechanisms of Gonadal Steroids Action in Adipose Tissue.

Agata Wawrzkiewicz-Jałowiecka, Anna Lalik, Graça Soveral

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 2 pooled it
3.2field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 2 syntheses or guidelines pooled it, 36 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Flavonoids as Modulators of Potassium Channels.International journal of molecular sciences · 2023
    Review
  17. Aquaporins in Obesity.Advances in experimental medicine and biology · 2023
    Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

Agata Wawrzkiewicz-JałowieckaDepartment of Physical Chemistry and Technology of Polymers, Silesian University of Technology, 44-100 Gliwice, Poland.ORCID 0000-0001-6885-3956
Anna LalikDepartment of Systems Biology and Engineering, Silesian University of Technology, Akademicka 16, 44-100 Gliwice, Poland.ORCID 0000-0003-4856-9821
Graça SoveralFaculty of Pharmacy, Research Institute for Medicines (iMed.ULisboa), Universidade de Lisboa, 1649-003 Lisboa, Portugal.ORCID 0000-0001-8487-110X
Silesian University of Technology · PLUniversity of Lisbon · PT

Funding

Politechnika Śląska 04/040/SDU/10-22-01
6 · The paper itself

Abstract

The gonadal steroids, including androgens, estrogens and progestogens, are involved in the control of body fat distribution in humans. Nevertheless, not only the size and localization of the fat depots depend on the sex steroids levels, but they can also highly affect the functioning of adipose tissue. Namely, the gonadocorticoids can directly influence insulin signaling, lipid metabolism, fatty acid uptake and adipokine production. They may also alter energy balance and glucose homeostasis in adipocytes in an indirect way, e.g., by changing the expression level of aquaglyceroporins. This work presents the recent advances in understanding the molecular mechanism of how the gonadal steroids influence the functioning of adipose tissue leading to a set of detrimental metabolic consequences. Special attention is given here to highlighting the sexual dimorphism of adipocyte functioning in terms of health and disease. Particularly, we discuss the molecular background of metabolic disturbances occurring in consequence of hormonal imbalance which is characteristic of some common endocrinopathies such as the polycystic ovary syndrome. From this perspective, we highlight the potential drug targets and the active substances which can be used in personalized sex-specific management of metabolic diseases, in accord with the patient's hormonal status.

Indexed as

AdipocytesAdipose TissueAnimalsAquaporinsBody Fat DistributionFemaleGonadal Steroid HormonesHumansInsulin ResistanceLipogenesisMaleMetabolic DiseasesMicroRNAsPolycystic Ovary SyndromeSex FactorsSteroidsAquaporinsGonadal Steroid HormonesMicroRNAsSteroidsadipokinesadipose tissueaquaporinsinsulin sensitivitylipid metabolismmetabolic disordersmicroRNAmicroRNA-oriented therapypolycystic ovary syndromesex hormones

Identifiers

PMID34069293
PMCPMC8157194
OpenAlexW3161019675

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.